Agenda I status surely improves the degree of complexity for any study research. For example, all scientists—no matter whether preclinical or clinical—will have to acquire Routine I study registrations. 21 CFR area 1301.eighteen. Against this, researchers who have DEA Practitioner registrations in Schedules II–V (which most medical profession